← Back to Search

CTU vs IVU Scans for Bladder Cancer

N/A
Waitlist Available
Led By Chaan Ng, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who had cystectomies for bladder cancer
Patients with upper tract TCC
Must not have
Allergy to intravenous CT contrast media
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare CTU and IVU scans in order to determine if CTU can be used effectively by itself to check the status of urothelial cancer.

Who is the study for?
This trial is for adults over 18 with confirmed urothelial cancer, including those who've had bladder tumors of Stage T3 or higher, cystectomies for bladder cancer, or upper tract TCC. Participants must consent and be referred for CTU as part of routine care. It's not suitable for individuals with high serum creatinine levels (>2), contrast media allergies, women who could become pregnant, or those who have had a ureteral stint placed or removed within six weeks.
What is being tested?
The study compares the effectiveness of Computed Tomography Urography (CTU) versus Intravenous Urography (IVU) in evaluating urothelial cancers. The aim is to determine if CTU can be used alone to assess these cancers effectively in future patients.
What are the potential side effects?
Potential side effects may include allergic reactions to the contrast media used during scans and kidney function impairment due to the substances injected into veins before imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had surgery to remove my bladder due to cancer.
Select...
I have cancer in the upper part of my urinary system.
Select...
My cancer is confirmed to be transitional cell carcinoma.
Select...
My bladder cancer is at an advanced stage.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am allergic to IV dye used in CT scans.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CTU to IVU Technical Performance Comparison: Opacification + Ability to Visualize Urothelial Segments

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CTU + IVUExperimental Treatment2 Interventions
CTU = Computed Tomography Urography + IVU = Intravenous Urography

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,074 Previous Clinical Trials
1,803,214 Total Patients Enrolled
GE HealthcareIndustry Sponsor
303 Previous Clinical Trials
633,822 Total Patients Enrolled
Chaan Ng, MDPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
165 Total Patients Enrolled

Media Library

Computed Tomography Urography (CTU) Clinical Trial Eligibility Overview. Trial Name: NCT00567684 — N/A
Bladder Cancer Research Study Groups: CTU + IVU
Bladder Cancer Clinical Trial 2023: Computed Tomography Urography (CTU) Highlights & Side Effects. Trial Name: NCT00567684 — N/A
Computed Tomography Urography (CTU) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00567684 — N/A
~49 spots leftby Nov 2034
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top